Physical healthcare of people with severe mental illness: Everybody's business!

Mental Health in Family Medicine

Volumn 7, Issue 2, 2010, Pages 115-122

  Vasudev, Kamini ^a   Martindale, Brian V ^b  

^a Monkwearmouth Hospital ^*  (United Kingdom)

^b Monkwearmouth Hospital   (United Kingdom)

Author keywords

Audit; Physical healthcare; Severe mental illness

Indexed keywords

ADULT; ARTICLE; FEMALE; HEALTH CARE; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; MALE; MEDICAL AUDIT; MEDICAL EXAMINATION; MENTAL DISEASE; PRIMARY HEALTH CARE; PSYCHIATRIST; PSYCHOLOGIST; PSYCHOSIS;

EID: 77956488843     PISSN: 1756834X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Auquier P, Lancon C, Rouillon F, Lader M and Holmes C. Mortality in schizophrenia. Pharmacoepidemiology and Drug Safety 2006;15:873-9.
2. McCreadie RG, Scottish Schizophrenia Lifestyle Group. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. British Journal of Psychiatry 2003;183:534-9.
3. Von Hausswolff-Juhlin Y, Bjartveit M, Lindstrom E and Jones P. Schizophrenia and physical health problems. Acta Psychiatrica Scandinavica 2009;438(suppl):15-21.
4. Haddad P. Weight change with atypical antipsychotics in the treatment of schizophrenia. Journal of Psychopharmacology 2005;19 (suppl):16-27.
5. Bushe C and Paton C. The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link? Journal of Psychopharmacology 2005;19 (suppl):76-83.
6. Lieberman JA, Stroup TS, McEnvoy JP et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 2005;353:1209-23.
7. National Institute for Health and Clinical Excellence. Clinical Guideline 82. Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care (update). London: NICE, 2009.
8. Taylor D, Paton C and Kerwin R. The Maudsley Prescribing Guidelines (9e). London: Informa Healthcare, 2007.
9. Tarrant CJ. Blood glucose testing for adults prescribed atypical antipsychotics in primary and secondary care. Psychiatric Bulletin 2006;30:286-8.
10. Feeney L and Mooney M. Atypical antipsychotic monitoring in the Kilkenny Mental Health Services. Irish Journal of Psychological Medicine 2005;22:101-2.
11. Barnes TR, Paton C, Cavanagh MR, Hancock E and Taylor DM. A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin 2007;33:1397-403.
12. Osborn DP, Nazareth I, Wright CA and King MB. Impact of nurse-led intervention to improve screening for cardiovascular risk factors in people with severe mental illnesses. Phase-two cluster randomized feasibility trial of community mental health teams. BMC Health Services Research 2010;10:61.
13. Gonzalez C, Ahammed N and Fisher R. Improving physical health monitoring for out-patients on antipsychotic medication. The Psychiatrist 2010;34:91-4.
14. Northumberland Tyne and Wear NHS Trust. Clinical policies. NTW(C)29: Physical Assessment - V03, February 2009, Appendix 3, Guidance for ECG monitoring. www.ntw.nhs.uk
15. British Medical Association and NHS Employers. Quality and Outcomes Framework Guidance for GMS Contract 2009/2010. London: BMA and NHS Employers, 2009. www.nhsemployers.org
16. Subramaniam M, Pek E, Verma S, Chan YH and Chong SA. Diagnostic stability two years after treatment initiation in the early psychosis intervention programme in Singapore. Australian and New Zealand Journal of Psychiatry 2007;41:495-500.
17. Fraguas D, de Castro MJ, Medina O et al. Does diagnostic classification of early onset psychosis change over follow-up? Child Psychiatry and Human Development 2008;39:137-45.
18. Shiers D, Jones PB and Field S. Early intervention in psychosis: keeping the body in mind. British Journal of General Practice 2009;59:395-6.
19. Oud MJ, Schuling J, Slooff CJ et al. Care for patients with severe mental illness: the general practitioner's role perspective. BMC Family Practice 2009;10:29.